Literature DB >> 11893108

Outcome analysis of pancreaticoduodenectomy at a community hospital.

Alan Afsari1, Zhou Zhandoug, Shun Young, Lorenzo Ferguson, Sumet Silapaswan, Vijay Mittal.   

Abstract

There is an ongoing debate about the proposed regionalization of pancreaticoduodenectomies. The purpose of our study is to demonstrate that good outcomes can be achieved in a well-managed low-volume community hospital. We retrospectively analyzed pathologic findings, morbidity, mortality, and one-year survival in 32 patients who underwent pancreaticoduodenectomy at Providence Hospital over a 10-year period and compared these results with data collected at Johns Hopkins, and the Mayo Clinic. The patients had a mean age of 68.5 +/- 2.96 years; 56.3 per cent were female and 71.9 per cent were white. Overall in our series 90.6 per cent of specimens were found to be malignant, which is statistically higher than the 68 per cent at Johns Hopkins (P = 0.013) and not significantly different from Mayo Clinic (76%). The 30-day mortality rate at Providence Hospital was 3.1 per cent, which is not statistically different from Johns Hopkins (1.3%) and Mayo Clinic (3.6%). One-year survival rate at Providence Hospital was 59.4 per cent, which is significantly different from 79 per cent at Johns Hopkins (P = 0.016). The one-year survival rate at Providence Hospital is higher than an approximately 50 per cent average reported nationally. The postoperative complication rate was 62.5 per cent; the most common complication was delayed early gastric emptying (28.1%). A statistical difference in morbidity exists between Providence Hospital and Johns Hopkins (P = 0.027) but not between Providence Hospital and Mayo Clinic (46%). The higher rate of malignant disease treated in the population at Providence Hospital may contribute to a higher complication rate and lower one-year survival rate than the reported rates at Johns Hopkins because of the poorer health of cancer patients. However, statistical analysis of mortality rates for pancreaticoduodenectomy at Providence Hospital show no difference from mortality rates at Johns Hopkins and Mayo Clinic. Therefore in low-volume community hospitals pancreaticoduodenectomy can be performed safely as evidenced by a comparable low mortality rate and a high one-year survival rate.

Entities:  

Mesh:

Year:  2002        PMID: 11893108

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  16 in total

1.  Achieving good perioperative outcomes after pancreaticoduodenectomy in a low-volume setting: a 25-year experience.

Authors:  Aljamir D Chedid; Marcio F Chedid; Leonardo V Winkelmann; Tomaz J M Grezzana Filho; Cleber D P Kruel
Journal:  Int Surg       Date:  2015-04

2.  Striving for a better operative outcome: 101 pancreaticoduodenectomies.

Authors:  A W C Kow; S P Chan; A Earnest; C Y Chan; K Lim; S Y Chong; K H Lim; C K Ho; S P Chew; K H Liau
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

3.  Pancreaticoduodenal resection for malignancy in a low-volume center: long-term outcomes from a developing country.

Authors:  Abu Bakar Hafeez Bhatti; Mohammad Aasim Yusuf; Syed Ather Saeed Kazmi; Aamir Ali Syed
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

4.  Outcome of Pancreaticoduodenectomy at Low-Volume Centre in Tier-II City of India.

Authors:  Kumar Vinchurkar; Vishwanath M Pattanshetti; Manoj Togale; Santosh Hazare; Varadraj Gokak
Journal:  Indian J Surg Oncol       Date:  2018-04-06

5.  Surgeon volume versus morbidity and cost in patients undergoing pancreaticoduodenectomy in an academic community medical center.

Authors:  Timothy J Kennedy; Maria A Cassera; Ronald Wolf; Lee L Swanstrom; Paul D Hansen
Journal:  J Gastrointest Surg       Date:  2010-07-30       Impact factor: 3.452

6.  Omental flap in pancreaticoduodenectomy for protection of splanchnic vessels.

Authors:  Atsuyuki Maeda; Tomoki Ebata; Hideyuki Kanemoto; Kazuya Matsunaga; Etsuro Bando; Shigeki Yamaguchi; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

7.  Interferon receptor alpha/beta is associated with improved survival after adjuvant therapy in resected pancreatic cancer.

Authors:  Reza F Saidi; Stephen G Remine; Michael J Jacobs
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

8.  Impact of surgical volume on nationwide hospital mortality after pancreaticoduodenectomy.

Authors:  Chul-Gyu Kim; Sungho Jo; Jae Sun Kim
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

9.  Complications of pancreatic surgery.

Authors:  Choon-Kiat Ho; Jörg Kleeff; Helmut Friess; Markus W Büchler
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

10.  National failure to operate on early stage pancreatic cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.